H2Bloc Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Famotidine

Indications/Uses

FC tab: Short-term treatment of active duodenal ulcer, active benign gastric ulcer, GERD. Maintenance therapy for duodenal ulcer after healing of an active ulcer. Pathological hypersecretory conditions (eg, Zollinger-Ellison syndrome, multiple endocrine adenomas. Powd for inj: Hospitalized patients w/ pathological hypersecretory conditions or intractable ulcer. Short-term treatment of active duodenal ulcer, active benign gastric ulcer, GERD, pathological hypersecretory conditions (eg, Zollinger-Ellison syndrome, multiple endocrine adenomas, upper GI bleeding due to peptic ulcer, hemorrhagic gastritis). Control of stress-induced upper GI bleeding.

Click to view H2Bloc detailed prescribing information

Dosage/Direction for Use

FC tab Adult Ulcer Treatment: 40 mg/day at bedtime or 20 mg bid for 4-8 wk depending on patient's response. Maintenance: 20 mg/day at bedtime. Childn 1-16 yr Initially 0.5 mg/kg/day, either in single dose at night or in 2 divided doses; up to 40 mg/day. GERD Adult Treatment: 20 mg (1 tab in the morning & 1 tab at bedtime) for 6-12 wks or up to 40 mg bid if there is esophageal erosion or ulceration. Maintenance: 20 mg tab tid (1 tab in the morning & 1 tab at bedtime). Childn 1-16 yr 0.5 mg/kg bid up to 40 mg bid. Pathological hypersecretory conditions 20 mg every 6 hrs, increased & continued as long as clinically indicated; max: 800 mg/day. Powd for inj Adult Upper GI bleeding & pathologic hypersecretory states (eg, Zollinger-Ellison syndrome, multiple endocrine adenomas) or intractable ulcer 20 mg every 12 hr by IV inj or infusion or IM. Control of stress-induced upper GI bleeding 20 mg every 12 hr by IV inj or infusion or IM. Post-op stress: Administer for 3 days. Other physical stress: Administer for 7 days. Active duodenal ulcer 20 mg every 12 hr by IV inj or infusion. Active benign gastric ulcer 20 mg every 12 hr by IV inj or infusion. Childn 1-16 yr 0.5 mg/kg/day every 12 hr by IV inj or infusion. Max: 40 mg/day.

Click to view H2Bloc detailed prescribing information

Overdosage

View H2Bloc overdosage for action to be taken in the event of an overdose.

Contraindications

Hypersensitivity to famotidine, other H₂-receptor antagonists.

Click to view H2Bloc detailed prescribing information

Special Precautions

Do not administer in cases of minor GI complaints. Monitor blood count & liver function. Avoid abrupt w/drawal in case of long-standing ulcer disease. Risk of community- or hospital-acquired pneumonia. Renal impairment. May impair ability to drive or operate machines. Pregnancy & lactation.

Click to view H2Bloc detailed prescribing information

Use In Pregnancy & Lactation

Click to view H2Bloc detailed prescribing information

Adverse Reactions

Constipation, diarrhea, dizziness & headache.

Click to view H2Bloc detailed prescribing information

Drug Interactions

May reduce uptake w/ antacids. Reduced absorption of atazanavir; ketoconazole & itraconazole; sucralfate. Inhibits renal tubular secretion w/ probenecid.

Click to view H2Bloc detailed prescribing information

Caution For Usage

For caution against possible variation of physical aspect of medicine... Click to view H2Bloc detailed prescribing information

Storage

View H2Bloc storage conditions for details to ensure optimal shelf-life.

Description

View H2Bloc description for details of the chemical structure and excipients (inactive components).

Action

View H2Bloc mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Antacids, Antireflux Agents & Antiulcerants

ATC Classification

A02BA03 - famotidine ; Belongs to the class of H2-receptor antagonists. Used in the treatment of peptic ulcer and gastro-oesophageal reflux disease (GERD).

Regulatory Classification

Presentation/Packing

Form

H2Bloc FC tab 20 mg

Packing/Price

50's (P1,225/pack)

Form

H2Bloc powd for inj 20 mg

Packing/Price

10 × 1's (P2,160/box)

H2Bloc

famotidine

Manufacturer:

UNILAB, Inc

Distributor:

UNILAB, Inc